N-Propionylated Group B Meningococcal Polysaccharide Mimics a Unique Bactericidal Capsular Epitope in Group B Neisseria meningitidis
Open Access
- 2 June 1997
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 185 (11) , 1929-1938
- https://doi.org/10.1084/jem.185.11.1929
Abstract
The N-propionylated group B meningococcal polysaccharide (NPrGBMP) mimics a unique protective epitope on the surface of group B meningococci (GBM) and Escherichia coli K1. Using a series of monoclonal antibodies (mAbs) induced by the NPrGBMP–monomeric tetanus toxoid (TT) conjugate vaccine it was demonstrated that mAbs having specificities for both extended and conventional short segments of the NPrGBMP were formed, but only the former were bactericidal, and/or gave passive protection against live challenge by GBM. The failure of mAbs specific for short epitopes to protect was further established when (NeuPr)4–TT was used as the vaccine. Of all the mAbs produced that were specific for short internal segments of the NPrGBMP, none were protective, despite the fact that most of them cross-react with the GBM capsular polysaccharide. In contrast, most of the protective mAbs produced by NPrGBMP– TT did not recognize the group B meningococcal polysaccharide (GBMP) unless it was present in its aggregated high molecular weight form. The bactericidal epitope mimicked by the NPrGBMP was shown to be ubiquitous in the capsule of both GBM and E. coli K1 using immunogold labeling techniques and, because of its unique properties, its identification could be significant in the development of a comprehensive conjugate vaccine against group B meningococcal meningitis. This is because most known human α(2–8)-polysialic acid self-antigens can be accommodated in 30–50 α(2–8)-linked sialic acid residues, which is roughly equivalent to an 11-kD length of the GBMP. It has been hypothesized that the formation of the protective epitope on the surface of GBM is due to the interaction of helical segments of the GBMP with another molecule and that the protective epitope is mimicked by the NPrGBMP. Support for the above hypothesis is provided by the fact that the protective NPrGBMP epitope has a similar unusual length dependency to that of the GBMP epitope.Keywords
This publication has 27 references indexed in Scilit:
- Preclinical Evaluation of a Novel Group B Meningococcal Conjugate Vaccine that Elicits Bactericidal Activity in both Mice and Nonhuman PrimatesThe Journal of Infectious Diseases, 1997
- Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazideVaccine, 1995
- Evidence for the Extended Helical Nature of Polysaccharide Epitopes. The 2.8 .ANG. Resolution Structure and Thermodynamics of Ligand Binding of an Antigen Binding Fragment Specific for .alpha.-(2.fwdarw.8)-Poly(sialic acid)Biochemistry, 1995
- Comparison of the conformation of the epitope of .alpha.(2 .fwdarw. 8) polysialic acid with its reduced and N-acyl derivativesBiochemistry, 1993
- Helical epitope of the group B meningococcal .alpha.(2-8)-linked sialic acid polysaccharideBiochemistry, 1992
- The epitope associated with the binding of the capsular polysaccharide of the group B meningococcus and of Escherichia coli K1 to a human monoclonal macroglobulin, IgMNOV.The Journal of Experimental Medicine, 1988
- N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis.The Journal of Experimental Medicine, 1987
- Occurrence of α2–8 linked polysialosyl units in a neural cell adhesion moleculeBiochemical and Biophysical Research Communications, 1983
- Immunologic Response of Man to Group B Meningococcal Polysaccharide VaccinesThe Journal of Infectious Diseases, 1972
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957